{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    11,
    12,
    13,
    14,
    16,
    17,
    18,
    19,
    22,
    23,
    24,
    25,
    26,
    27,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Avelumab",
        "type": {
          "id": "90434fa2-6aae-4cd6-97c7-6844f363fd90",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "9ad91133-23a5-4485-9ca4-a605b6a16eee",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Fully human monoclonal antibody (mAb) of the immunoglobulin (Ig) G1 isotype that selectively binds to PD-L1.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Axitinib",
        "type": {
          "id": "c0080407-e307-4711-804e-7659b7ffe2cc",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "3a86aa0b-deec-4418-a1cf-00932bcbdb98",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Oral, small molecule, tyrosine kinase inhibitor (TKI) selective for VEGFRs 1, 2, and 3.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Sunitinib",
        "type": {
          "id": "9915fad1-c6a3-4533-9628-d5d7ee1358be",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "7557a5d8-a355-4e12-b222-d0ddab506243",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Oral, multitargeted TKI of KIT, PDGFRs, VEGFRs, RET, and FLT3; used as monotherapy in the control arm.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Anti-emetic treatment",
        "type": {
          "id": "5c8f6911-8651-46a0-b0a9-a641fa4f89df",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "7017ba9b-d2cc-4921-9bae-b41d5717c92c",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted supportive care for prophylaxis or treatment of nausea/vomiting.",
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Hematopoietic Growth Factors",
        "type": {
          "id": "965430f6-abf0-4ece-aa86-8aefc2ee45d6",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "a8005aad-3083-4d19-8912-5e9166db5f07",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Mentioned under concomitant treatments section.",
        "administrationIds": [
          "admin_5"
        ]
      },
      {
        "id": "int_6",
        "name": "CYP3A4/5 Inhibitors and Inducers",
        "type": {
          "id": "6080534c-caa3-46b4-8611-3d6e11e8dd34",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "0c5d85ab-8333-45a0-830f-ff6e5e0b2601",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Medications that may interact with axitinib or sunitinib metabolism."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Avelumab (MSB0010718C)",
        "administrableDoseForm": {
          "id": "4bf55218-d275-4b78-8a45-8cd6402149fc",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "41fa8e92-59a7-4d14-84d2-0bd2f1e21561",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "1489a920-9bef-4d1b-a16c-1a5527f8fbf8",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified in provided text",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Pfizer and Merck KGaA/EMD Serono"
      },
      {
        "id": "prod_2",
        "name": "Axitinib (INLYTA速)",
        "administrableDoseForm": {
          "id": "e491febe-49a7-44ae-a08d-83c795a3583e",
          "code": "C42998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Tablet",
          "standardCode": {
            "id": "7ede3d67-32d2-430d-8b7f-a329db1cc581",
            "code": "C42998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Tablet",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "f2cdbfb6-ab90-480e-8014-737d78444ac6",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified in provided text",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Pfizer"
      },
      {
        "id": "prod_3",
        "name": "Sunitinib Malate (SUTENT速)",
        "administrableDoseForm": {
          "id": "0d92d15d-569b-4722-ace0-b755a782114f",
          "code": "C25158",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Capsule",
          "standardCode": {
            "id": "4a9cf9ef-505a-412b-86ea-916f97389b23",
            "code": "C25158",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Capsule",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "f6676e33-0c5b-4d3a-bf18-7a38efa3c3ec",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "50 mg",
        "substanceIds": [
          "sub_3"
        ],
        "manufacturer": "Pfizer"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Arm A: Avelumab regimen",
        "instanceType": "Administration",
        "dose": "10 mg/kg",
        "doseFrequency": "every 2 weeks",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression, unacceptable toxicity, or withdrawal"
      },
      {
        "id": "admin_2",
        "name": "Arm A: Axitinib regimen",
        "instanceType": "Administration",
        "dose": "5 mg",
        "doseFrequency": "twice daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Continuous"
      },
      {
        "id": "admin_3",
        "name": "Arm B: Sunitinib regimen",
        "instanceType": "Administration",
        "dose": "50 mg",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "4 weeks on, 2 weeks off (Schedule 4/2) in 6-week cycles"
      },
      {
        "id": "admin_4",
        "name": "Axitinib Dose Level -1",
        "instanceType": "Administration",
        "dose": "3 mg",
        "doseFrequency": "twice daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Dose reduction for toxicity"
      },
      {
        "id": "admin_5",
        "name": "Axitinib Dose Level -2",
        "instanceType": "Administration",
        "dose": "2 mg",
        "doseFrequency": "twice daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Dose reduction for toxicity"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Avelumab",
        "instanceType": "Substance",
        "description": "Anti-PD-L1 monoclonal antibody"
      },
      {
        "id": "sub_2",
        "name": "Axitinib",
        "instanceType": "Substance",
        "description": "VEGFR tyrosine kinase inhibitor"
      },
      {
        "id": "sub_3",
        "name": "Sunitinib Malate",
        "instanceType": "Substance",
        "description": "Multitargeted tyrosine kinase inhibitor"
      }
    ],
    "medicalDevices": [
      {
        "id": "dev_1",
        "name": "Home Blood Pressure Monitoring Device",
        "instanceType": "MedicalDevice",
        "manufacturer": "Not specified"
      }
    ],
    "summary": {
      "interventionCount": 6,
      "productCount": 3,
      "deviceCount": 1
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Avelumab",
        "role": "Investigational Product",
        "description": "Fully human monoclonal antibody (mAb) of the immunoglobulin (Ig) G1 isotype that selectively binds to PD-L1."
      },
      {
        "name": "Axitinib",
        "role": "Investigational Product",
        "description": "Oral, small molecule, tyrosine kinase inhibitor (TKI) selective for VEGFRs 1, 2, and 3."
      },
      {
        "name": "Sunitinib",
        "role": "Comparator",
        "description": "Oral, multitargeted TKI of KIT, PDGFRs, VEGFRs, RET, and FLT3; used as monotherapy in the control arm."
      },
      {
        "name": "Anti-emetic treatment",
        "role": "Concomitant Medication",
        "description": "Permitted supportive care for prophylaxis or treatment of nausea/vomiting."
      },
      {
        "name": "Hematopoietic Growth Factors",
        "role": "Concomitant Medication",
        "description": "Mentioned under concomitant treatments section."
      },
      {
        "name": "CYP3A4/5 Inhibitors and Inducers",
        "role": "Concomitant Medication",
        "description": "Medications that may interact with axitinib or sunitinib metabolism."
      }
    ],
    "products": [
      {
        "name": "Avelumab (MSB0010718C)",
        "doseForm": "Solution",
        "strength": "Not specified in provided text",
        "manufacturer": "Pfizer and Merck KGaA/EMD Serono"
      },
      {
        "name": "Axitinib (INLYTA速)",
        "doseForm": "Tablet",
        "strength": "Not specified in provided text",
        "manufacturer": "Pfizer"
      },
      {
        "name": "Sunitinib Malate (SUTENT速)",
        "doseForm": "Capsule",
        "strength": "50 mg",
        "manufacturer": "Pfizer"
      }
    ],
    "substances": [
      {
        "name": "Avelumab",
        "description": "Anti-PD-L1 monoclonal antibody"
      },
      {
        "name": "Axitinib",
        "description": "VEGFR tyrosine kinase inhibitor"
      },
      {
        "name": "Sunitinib Malate",
        "description": "Multitargeted tyrosine kinase inhibitor"
      }
    ],
    "administrations": [
      {
        "name": "Arm A: Avelumab regimen",
        "dose": "10 mg/kg",
        "frequency": "every 2 weeks",
        "route": "Intravenous",
        "duration": "Until disease progression, unacceptable toxicity, or withdrawal"
      },
      {
        "name": "Arm A: Axitinib regimen",
        "dose": "5 mg",
        "frequency": "twice daily",
        "route": "Oral",
        "duration": "Continuous"
      },
      {
        "name": "Arm B: Sunitinib regimen",
        "dose": "50 mg",
        "frequency": "once daily",
        "route": "Oral",
        "duration": "4 weeks on, 2 weeks off (Schedule 4/2) in 6-week cycles"
      },
      {
        "name": "Axitinib Dose Level -1",
        "dose": "3 mg",
        "frequency": "twice daily",
        "route": "Oral",
        "duration": "Dose reduction for toxicity"
      },
      {
        "name": "Axitinib Dose Level -2",
        "dose": "2 mg",
        "frequency": "twice daily",
        "route": "Oral",
        "duration": "Dose reduction for toxicity"
      }
    ],
    "devices": [
      {
        "name": "Home Blood Pressure Monitoring Device",
        "manufacturer": "Not specified",
        "purpose": "Daily monitoring of blood pressure by patients at home"
      }
    ]
  }
}